HemoCue AB

Have you ever heard of HbA1c? HbA1c is a vital component in improving the quality of care for children living with type 1 diabetes in low- and middle-income countries. HbA1c levels represent the average blood sugar levels over the past 2-3 months. The use of point-of-care testing for HbA1c provides the opportunity for more timely changes of treatment, and by improved control of HbA1c, children suffering from diabetes can experience better outcomes. “The partnership between Novo Nordisk and HemoCue ensures availability of the HbA1c diabetes marker to children that otherwise would not have access to that marker. The Changing Diabetes in Children program has the potential of reaching 100.000 children in 30 different countries”, Kasper Oktavio Schweitz - EMBA, PhD, M.Sc. Schweitz, President at HemoCue. #AdvancingCare

At #HemoCue, part of Danaher Corporation, we thrive on a continuous improvement mindset powered by the Danaher Business System (DBS). #DBS is our cultural foundation, driving innovation and excellence - it's the way we work, the way we win. As we gear up for our annual Shingijutsu (Shin) Kaizen event later in October, our focus is on intensive preparation. This week-long event will involve complete leadership involvement and an emphasis on DBS principles to ensure we tackle the most critical issues effectively. During the SHIN event, five teams will address the most pressing challenges, aiming for innovative solutions. This collaborative effort underscores our commitment to tackling challenges head-on and fostering a culture of excellence. We look forward to the upcoming SHIN event and the breakthroughs it will bring. Join us in celebrating continuous improvement and innovation at HemoCue. See some snapshots from previous Kaizens!

The team exhibiting at #WONCA Europe Conference in Dublin has had a busy couple of days. Don't miss the chance to chat with Magnus Nordahl, Ismail Hosoglu, Oleksii Shalimov and Niamh Kilcawley, PhD, representing ACCUSCIENCE, HemoCue's channel partner in Ireland. Learn more about the benefits of using a system that provides results within minutes or even seconds, and discuss all things point-of-care testing with the team! Find them in booth #18 where they are showcasing products from our Hb and diabetes portfolios.

The team at #HemoCue India is ready to meet with participants at this year's #TRANSMEDCON 2024, the Annual National Conference of Indian Society of Transfusion Medicine (ISTM) in Mahabalipuram, Chennai.   Stop by booth #51 to chat with Punitha Kashinathan, Rakesh Gusidi, Balaji Reddy and Parimal Dikholkar and explore our Hb 301 system, Basic Connect, and other solutions. Did you know our Hb 301 system provides a result within 3 seconds? Ask for a demo to see it for yourself!   The team will be there today, September 27 until Sunday, September 28.   #AdvancingCare

Congratulations on your 40th anniversary, Danaher Corporation! This week marks a milestone as Danaher celebrates their 40th anniversary. We are so proud to be part of Danaher's journey, combining our capabilities to accelerate the real-life impact of tomorrow’s science and technology - together advancing care to improve human health. #AdvancingCare #speedoflife

Last week was #WorldPatientSafetyDay - a global initiative bringing together patients, healthcare professionals, policymakers and many others, to help raise awareness about the vital role of correct and timely diagnosis in improving patient safety. A diagnosis identifies a patient's health problem and is key to accessing the care and treatment they need. A diagnostic error is the failure to establish a correct and timely explanation of a patient's problem, which can include delayed, incorrect, or missed diagnoses, or a failure to communicate that explanation to the patient.* At #HemoCue, patient safety is a continuous commitment, not just a one-day focus. Hear from Global Product Managers Charlotta Blomstrand, Manuel Gonzalez Artunduaga and Michael Aistrup Nielsen on what they believe is important to improve patient safety and ensure the best outcomes for all. #AdvancingCare #PatientSafety *https://lnkd.in/eSNin93A

Maria Thue and Grethe Manford-Christiansen from #HemoCue Denmark are currently exhibiting at DEKS User Meeting (Danish Institute for External Quality Assurance for Laboratories in the health sector) in Kolding, Denmark. DEKS’ purpose is to increase patient safety through quality assurance of lab medical tests.   Reliable point-of-care testing plays a vital role in safeguarding patient outcomes. By delivering fast and accurate results, healthcare professionals can make timely decisions, reducing risks associated with delayed treatment. At HemoCue, we are committed to providing solutions that contribute directly to patient safety. Our point-of-care devices for hemoglobin, diabetes, and white blood cell count ensure that clinicians have the data they need, when they need it most.   If you're attending the event, stop by our booth and explore how your practice can benefit from our solutions. Grethe and Maria will be here until tomorrow, September 25, and look forward to seeing you!

Last week was #WorldPatientSafetyDay - a global initiative bringing together patients, healthcare professionals, policymakers and many others, to help raise awareness about the vital role of correct and timely diagnosis in improving patient safety. A diagnosis identifies a patient's health problem and is key to accessing the care and treatment they need. A diagnostic error is the failure to establish a correct and timely explanation of a patient's problem, which can include delayed, incorrect, or missed diagnoses, or a failure to communicate that explanation to the patient.* At #HemoCue, patient safety is a continuous commitment, not just a one-day focus. Hear from Global Product Managers Charlotta Blomstrand, Manuel Gonzalez Artunduaga and Michael Aistrup Nielsen on what they believe is important to improve patient safety and ensure the best outcomes for all. #AdvancingCare #PatientSafety *https://lnkd.in/eSNin93A

The team at #HemoCue India recently participated in a CME (Continuing Medical Education) event focusing on anemia-related topics. Organized by the Department of Community Medicine of Dr. Ram Manohar Lohia Institute of Medical Sciences, the event brought together public health specialists from across the country. It served as a great platform for knowledge-sharing and encouraged valuable discussions on how healthcare professionals, public health specialists and other important stakeholders can work together to improve anemia management in Uttar Pradesh.   Krishna Kumar Maheshwari presented HemoCue’s solutions for anemia screening and hosted a booth at the conference together with Farhan Khan, demonstrating the ease of use and fast time to result of the HemoCue Hb 301 Analyzer, highlighting how it can help healthcare professionals make quick, informed decisions for better patient outcomes.   “It’s been a privilege to participate in this CME at Dr. Ram Manohar Lohia Institute of Medical Sciences,” says Krishna. “With nearly 150 participants on-site and over 100 joining online, it was a fantastic opportunity to learn from healthcare experts who are making a difference on the ground.” #AdvancingCare

Sepsis is a life-threatening condition that can affect anyone and every minute counts in turning things around. Sepsis claims at least 11 million lives every year and is the number 1 cause of death in hospitals.* By spreading awareness about sepsis, its symptoms and its effects, we can help save lives. Today on World Sepsis Day, we are taking the opportunity to do just that. Early detection of sepsis through quick and accurate diagnostics is essential in the fight against sepsis. We are proud to support the fight by providing solutions that can help healthcare professionals in the early diagnosis of sepsis and other severe bacterial infections. Watch the video to learn more and head over to https://lnkd.in/dZKCbwF to keep updated with information and news about sepsis. #StopSepsis #SaveLives #WorldSepsisDay *https://lnkd.in/grv6y2pt